• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The importance of residual renal function in chronic dialysed patients.残余肾功能在慢性透析患者中的重要性。
J Med Life. 2009 Apr-Jun;2(2):199-206.
2
[Maintaining residual renal function in patients on dialysis].[维持透析患者的残余肾功能]
Nephrol Ther. 2013 Nov;9(6):403-7. doi: 10.1016/j.nephro.2013.05.001. Epub 2013 Jun 12.
3
Residual renal function: considerations on its importance and preservation in dialysis patients.残余肾功能:关于其在透析患者中的重要性及保护的思考
Semin Dial. 2004 May-Jun;17(3):196-201. doi: 10.1111/j.0894-0959.2004.17306.x.
4
Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors.透析患者残余肾功能的保留:透析技术相关因素的影响
Perit Dial Int. 2001 Jan-Feb;21(1):52-7.
5
Is it time to revisit residual renal function in haemodialysis?是时候重新审视血液透析中的残余肾功能了吗?
Nephrology (Carlton). 2007 Jun;12(3):209-17. doi: 10.1111/j.1440-1797.2007.00795.x.
6
Predictors of Residual Renal Function Decline in Peritoneal Dialysis Patients: The ANZ Trial.腹膜透析患者残余肾功能下降的预测因素:澳新试验
Perit Dial Int. 2017 May-Jun;37(3):283-289. doi: 10.3747/pdi.2016.00206. Epub 2016 Dec 1.
7
Strategies for the preservation of residual renal function in pediatric dialysis patients.小儿透析患者残余肾功能的保护策略。
Pediatr Nephrol. 2014 May;29(5):825-36; quiz 832. doi: 10.1007/s00467-013-2554-0. Epub 2013 Jul 19.
8
Emerging importance of residual renal function in end-stage renal failure.残余肾功能在终末期肾衰竭中的重要性日益凸显。
Semin Dial. 2011 Sep-Oct;24(5):487-94. doi: 10.1111/j.1525-139X.2011.00968.x.
9
Preservation of residual renal function in dialysis patients.透析患者残余肾功能的保留
Adv Perit Dial. 2011;27:112-7.
10
Incremental Hemodialysis - A European Perspective.增量血液透析——欧洲视角
Semin Dial. 2017 May;30(3):270-276. doi: 10.1111/sdi.12583. Epub 2017 Feb 9.

引用本文的文献

1
Benefits of Preserving Residual Urine Output in Patients Undergoing Maintenance Haemodialysis.维持性血液透析患者保留残余尿量的益处。
Int J Nephrol Renovasc Dis. 2023 Oct 17;16:231-240. doi: 10.2147/IJNRD.S421533. eCollection 2023.
2
Determining factors of diuresis in chronic kidney disease patients initiating hemodialysis.开始血液透析的慢性肾脏病患者利尿的决定因素
J Med Life. 2015 Jul-Sep;8(3):371-7.
3
The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy.慢性肾病患者中肾毒性药物处方的负担:意大利南部一项基于人群的回顾性研究。
PLoS One. 2014 Feb 18;9(2):e89072. doi: 10.1371/journal.pone.0089072. eCollection 2014.
4
Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis.不同透析方式的慢性肾脏病和终末期肾病患者发生消化性溃疡出血的风险不同。
Dig Dis Sci. 2014 Apr;59(4):807-13. doi: 10.1007/s10620-013-2973-6. Epub 2013 Dec 8.

本文引用的文献

1
Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.头孢唑林联合奈替米星与头孢唑林联合头孢他啶治疗持续性非卧床腹膜透析相关性腹膜炎:对残余肾功能的影响
Kidney Int. 2005 Nov;68(5):2375-80. doi: 10.1111/j.1523-1755.2005.00700.x.
2
Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients.新发病例腹膜透析患者不同尿毒症溶质的腹膜清除率和肾脏清除率的时间曲线
Am J Kidney Dis. 2005 Sep;46(3):512-9. doi: 10.1053/j.ajkd.2005.05.016.
3
Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.血清胎球蛋白-A与腹膜透析患者营养不良、炎症、动脉粥样硬化及瓣膜钙化综合征的关联及预后
Nephrol Dial Transplant. 2005 Aug;20(8):1676-85. doi: 10.1093/ndt/gfh891. Epub 2005 May 17.
4
Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.循环可溶性血管细胞黏附分子1:与腹膜透析患者残余肾功能、心脏肥大及预后的关系
Am J Kidney Dis. 2005 Apr;45(4):715-29. doi: 10.1053/j.ajkd.2004.12.012.
5
Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients.血浆白细胞介素-6可预测血液透析患者的心血管死亡率。
Am J Kidney Dis. 2005 Feb;45(2):324-33. doi: 10.1053/j.ajkd.2004.09.018.
6
Evaluation of handgrip strength as a nutritional marker and prognostic indicator in peritoneal dialysis patients.评估握力作为腹膜透析患者营养指标和预后指标的作用。
Am J Clin Nutr. 2005 Jan;81(1):79-86. doi: 10.1093/ajcn/81.1.79.
7
Resting energy expenditure and subsequent mortality risk in peritoneal dialysis patients.腹膜透析患者的静息能量消耗及后续死亡风险
J Am Soc Nephrol. 2004 Dec;15(12):3134-43. doi: 10.1097/01.ASN.0000144206.29951.B2.
8
Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients?在新的血液透析患者中,保留残余肾功能是否应以容量超负荷及其后果左心室肥厚为代价?
Ren Fail. 2004 Jul;26(4):405-9. doi: 10.1081/jdi-120039825.
9
Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.炎症、残余肾功能和心脏肥大相互关联,并产生不利的综合作用,增加腹膜透析患者的死亡率和心血管死亡风险。
J Am Soc Nephrol. 2004 Aug;15(8):2186-94. doi: 10.1097/01.ASN.0000135053.98172.D6.
10
Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients.比较新发病的持续性非卧床腹膜透析(CAPD)患者和自动化腹膜透析患者的超滤、钠清除及肾功能的时间曲线。
Am J Kidney Dis. 2004 Jul;44(1):132-45. doi: 10.1053/j.ajkd.2004.03.035.

残余肾功能在慢性透析患者中的重要性。

The importance of residual renal function in chronic dialysed patients.

作者信息

Rădulescu Daniela, Ferechide Dumitru

机构信息

"Carol Davila" University of Medicine and Pharmacy, Nephrology Clinic, "Sf Ioan" Clinical Emergency Hospital, Bucharest, Romania.

出版信息

J Med Life. 2009 Apr-Jun;2(2):199-206.

PMID:20108541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3018976/
Abstract

In the last decade, many researches have reached to the conclusion that preservation of residual renal function (RRF) is important after initiating dialysis, as well as in the predialysis period. RRF has been proven to contribue to the quality of life of dialysis patients. Longer preservation of RRF provides a better small and middle molecule removal, improved volemic status and arterial pressure control, diminished risk of vascular and valvular calcification due to better phosphate removal. Deterioration of RRF results in worsening of anemia, inflammation and malnutrition. It is now proven a direct relationship between RRF value and survival in dialysis patient. Several therapeutical intervention have been proven to ameliorate the decline of RRF in dialysis patients. Some of them are identical with those before initiating dialysis: ACE-inhibitors and/or angiotensin-receptor blockers, limiting the use of nephrotoxic drugs, avoiding contrast media procedures, adequate control of blood pressure. Others are specific for dialysis period: adequate dialysis dose, avoiding excessive ultrafiltration, preventing arterial hypotension during dialysis sessions, using biocompatible dialysis membranes, ultrapure water for dialysis, dietary interventions.

摘要

在过去十年中,许多研究得出结论,残余肾功能(RRF)的保留在开始透析后以及透析前期都很重要。RRF已被证明有助于透析患者的生活质量。RRF保留时间越长,小分子和中分子清除效果越好,血容量状态和动脉血压控制得到改善,由于更好地清除磷酸盐,血管和瓣膜钙化风险降低。RRF恶化会导致贫血、炎症和营养不良加重。现已证实RRF值与透析患者的生存率之间存在直接关系。已证明几种治疗干预措施可改善透析患者RRF的下降。其中一些与开始透析前的措施相同:使用血管紧张素转换酶抑制剂和/或血管紧张素受体阻滞剂、限制使用肾毒性药物、避免造影剂检查、充分控制血压。其他措施则是透析期特有的:足够的透析剂量、避免过度超滤、防止透析过程中动脉低血压、使用生物相容性透析膜、使用超纯水进行透析、饮食干预。